- Startseite
- Investoren
- Key Financials
Segmente 2022
in TCHF |
Plasma |
X-Ray |
Industrial |
Elimination |
Corporate |
Total Gruppe |
Nettoumsatz |
||||||
| Nettoumsatz mit Drittkunden | 381,424 | 129,944 | 75,026 | — | — | 586,395 |
| Umsatz mit anderen Segmenten | — | 407 | 13,616 | (14,023) | — | — |
Total Nettoumsatz |
381,424 | 130,351 | 88,643 | (14,023) | — | 586,395 |
Segmentergebnis |
94,497 | (3,104) | 10,868 | (1,227) | — | 101,033 |
| Nicht direkt zugewiesene Kosten | — | — | — | — | (2,059) | (2,059) |
Betriebsergebnis |
94,497 | (3,104) | 10,868 | (1,227) | (2,059) | 98,975 |
| Zinsertrag | — | — | — | — | — | 440 |
| Zinsaufwand | — | — | — | — | — | (1,715) |
| Gewinne/Verluste aus FairValue-Bewertung Derivaten, netto | — | — | — | — | — | (192) |
| Fremdwährungsgewinne/-verluste, netto | — | — | — | — | — | (2,140) |
Gewinn vor Steuern |
— | — | — | — | — | 95,368 |
| Ertragssteuern | — | — | — | — | — | (17,259) |
Reingewinn |
— | — | — | — | — | 78,109 |
EBITDA |
104,915 | 1,607 | 15,677 | (1,227) | (2,059) | 118,913 |
| EBITDA in % vom Nettoumsatz | 27.5% | 1.2% | 17.7% | 20.3% | ||
Aktiven und Passiven zum 31.12.2022 |
||||||
| Segmentaktiven | 216,730 | 103,496 | 88,108 | — | 148.467 | 556,801 |
| Segmentverbindlichkeiten | (75,364) | (53,689) | (17,222) | — | (78,994) | (225,269) |
Nettoaktiven |
141,365 | 49,807 | 70,886 | — | 69,473 | 331,532 |
Übrige Segmentinformationen |
||||||
| Investitionen Nutzungsrechte aus Leasing | 20,714 | 1,558 | 239 | — | — | 22,511 |
| Investitionen Sachanlagen und immaterielle Werte | 16,958 | 2,384 | 3,412 | — | — | 22,753 |
| Abschreibungen, Amortisationen und Wertberichtigungen | 10,419 | 4,711 | 4,809 | — | — | 19,939 |
| Veränderung Rückstellungen | (318) | 1,509 | (166) | — | — | 1,026 |
| Übriger nicht liquiditätswirksamer Aufwand/Ertrag |
(345) | 93 | 4 | 58 | 24 | (166) |
| Personalbestand am Jahresende | 998 | 430 | 335 | — | — | 1,763 |
Segmente
2021
in TCHF |
Plasma Control Technologies (PCT) |
X-Ray Systems (IXS) |
Industrial X-Ray Modules (IXM) |
ebeam Technologies (EBT) | Elimination Umsatz mit anderen Segmenten | Corporate | Total Gruppe |
Nettoumsatz |
|||||||
| Nettoumsatz mit Drittkunden | 306’091 | 138’371 | 69’259 | — | — | — | 513’721 |
| Umsatz mit anderen Segmenten | — | 535 | 9’687 | — | -10’222 | — | — |
| Total Nettoumsatz | 306’091 | 138’906 | 78’946 | — | -10’222 | — | 513’721 |
Resultate |
|||||||
| Segmentergebnis | 71’864 | 3’634 | 10’548 | — | 294 | — | 86’340 |
| Nicht direkt zugewiesene Kosten | — | — | — | — | — | -2’255 | -2’255 |
| Betriebsergebnis | 71’864 | 3’634 | 10’548 | — | 294 | -2’255 | 84’085 |
| Finanzaufwand | -5’106 | ||||||
| Finanzertrag | 3’229 | ||||||
| Gewinn vor Steuern | 82’208 | ||||||
| Ertragssteuern | -14’771 | ||||||
Reingewinn |
67’437 | ||||||
EBITDA |
80’487 | 8’931 | 15’292 | — | 294 | -2’255 | 102’749 |
| EBITDA in % vom Nettoumsatz | 26.3% | 6.4% | 19.4% | 20.0% | |||
Aktiven und Passiven zum 31.12.2021 |
|||||||
| Segmentaktiven | 153’907 | 116’142 | 85’470 | — | — | 134’897 | 490’415 |
| Segmentverbindlichkeiten | -50’890 | -75’497 | -20’290 | — | — | -68’757 | -215’435 |
|
Nettoaktiven |
103’017 | 40’645 | 65’180 | — | — | 66’140 | 274’981 |
Übrige Segmentinformationen |
|||||||
| Investitionen Nutzungsrechte aus Leasing | 1’165 | 861 | 1’597 | — | — | — | 3’623 |
| Investitionen Sachanlagen und immaterielle Werte | 6’586 | 1’870 | 3’011 | — | — | — | 11’467 |
| Abschreibungen, Amortisationen und Wertberichtigungen | 8’622 | 5’297 | 4’744 | — | — | — | 18’663 |
| Veränderung Rückstellungen | 262 | -1’887 | 77 | — | — | — | -1’549 |
| Übriger nicht liquiditätswirksamer Aufwand/Ertrag |
-203 | -293 | -47 | — | 24 | 400 | -119 |
| Personalbestand am Jahresende | 826 | 435 | 310 | — | — | — | 1’571 |
Segmente
2020
| In thousands of CHF | Industrial X-Ray Modules (IXM) |
ebeam Technologies (EBT) |
Plasma Control Technologies (PCT) |
X-Ray Systems (IXS) |
Elimination Umsatz mit anderen Segmenten | Corporate | Total Gruppe |
Net sales |
|||||||
| External net sales | 50’052 | 14’598 | 224’718 | 106’449 | — | — | 395’816 |
| Intersegment sales | 11’351 | — | — | 314 | -11’665 | — | — |
| Total net sales | 61’403 | 14’598 | 224’718 | 106’762 | -11’665 | — | 395’816 |
Earnings |
|||||||
| Segment operating income/(loss) |
3’997 | 2’242 | 41’781 | -6’677 | 156 | — | 41’498 |
| Unallocated costs | — | — | — | — | — | -2’169 | -2’169 |
| Operating income | 3’997 | 2’242 | 41’781 | -6’677 | 156 | -2’169 | 39’329 |
| Financing expenses | -8’657 | ||||||
| Financing income | 2’816 | ||||||
| Income before tax | 33’487 | ||||||
| Income tax | -5’827 | ||||||
| Net income | 27’661 | ||||||
| EBITDA | 8’956 | 3’344 | 49’338 | -1’009 | 156 | -2’169 | 58’616 |
| EBITDA in % of sales | 14.6% | 22.9% | 22.0% | -0.9% | 14.8% | ||
Assets and liabilities at Dec. 31, 2020 |
|||||||
| Segment assets | 83’828 | — | 129’908 | 124’183 | — | 91’351 | 429’271 |
| Segment liabilities | -16’793 | — | -44’235 | -86’261 | — | -67’025 | -214’315 |
| Net assets | 67’035 | — | 85’673 | 37’923 | — | 24’326 | 214’956 |
Other segment information |
|||||||
| Depreciation and amortization | 4’959 | 1’102 | 7’557 | 5’669 | — | — | 19’287 |
| Capital expenditure | 3’669 | 254 | 11’823 | 11’369 | — | — | 27’115 |
| Change in provisions | -35 | -364 | 700 | -353 | — | — | -52 |
| Other non-cash expense/(income) | 359 | -102 | 646 | -495 | 14 | 1’438 | 1’860 |
| Number of employees at year end | 293 | — | 679 | 431 | — | — | 1’403 |
Segments 2024
In thousands of CHF |
Plasma |
X-Ray |
Industrial |
Elimination |
Corporate |
Consolidated |
Net sales |
||||||
| External net sales | 247,391 | 115,836 | 82,135 | — | — | 445,362 |
| Intersegment sales | — | 52 | 12,436 | (12,488) | — | — |
Total net sales |
247,391 | 115,888 | 94,571 | (12,488) | — | 445,362 |
Segment operating income |
40,225 | (8,854) | 9,474 | (138) | — | 40,708 |
| Unallocated costs | — | — | — | — | (2,478) | (2,478) |
Operating income |
40,225 | (8,854) | 9,474 | (138) | (2,478) | 38,229 |
| lnterest income | — | — | — | — | — | 2,587 |
| lnterest (expenses) | — | — | — | — | — | (2,084) |
| Other financial expenses | — | — | — | — | — | (258) |
| Net losses on derivative fair value | — | — | — | — | — | (1,412) |
| Net gains on foreign exchange | — | — | — | — | — | 3,173 |
Income before tax |
— | — | — | — | — | 40,235 |
| lncome tax | — | — | — | — | — | (5,116) |
Net income |
— | — | — | — | — | 35,119 |
EBITDA |
52,734 | (4,306) | 14,567 | (138) | (2,478) | 60,380 |
| EBITDA in % of net sales | 21,3% | (3.7%) | 15,4% | 13,6% | ||
Assets and liabilities at Dec. 31, 2024 |
||||||
| Segment assets | 200,481 | 98,958 | 92,220 | — | 139,510 | 531,169 |
| Segment liabilities | (65,956) | (48,355) | (21,830) | — | (69,591) | (205,731) |
Net assets |
134,525 | 50,603 | 70,390 | — | 69,919 | 325,438 |
Other segment information |
||||||
| Additions to right-of-use asset | 4,630 | 2,311 | 1,544 | — | — | 8,484 |
| Additions to property, plant and equipment & intangible assets | 6,502 | 2,475 | 3,803 | — | — | 12,779 |
| Depreciation, amortization and impairment | 12,510 | 4,548 | 5,093 | — | — | 22,150 |
| Change in provisions | (450) | 45 | (42) | — | — | (447) |
| Other non-cash expense or (income) | (1,724) | (26) | 400 | (28) | 511 | (867) |
| Number of employees at year-end | 942 | 506 | 362 | — | — | 1,1810 |
Segmente 2023
In thousands of CHF |
Plasma |
X-Ray |
Industrial |
Elimination |
Corporate |
Consolidated |
Net sales |
||||||
| External net sales | 193,155 | 116,826 | 87,472 | — | — | 397,453 |
| Intersegment sales | — | 134 | 12,787 | (12,921) | — | — |
Total net sales |
193,155 | 116,961 | 100,258 | (12,921) | — | 397,453 |
Segment operating income |
7,192 | 671 | 19,580 | 761 | — | 28,204 |
| Unallocated costs | — | — | — | — | (3,226) | (3,226) |
Operating income |
7,192 | 671 | 19,580 | 761 | (3,226) | 24,978 |
| lnterest income | — | — | — | — | — | 1,632 |
| lnterest (expenses) | — | — | — | — | — | (2,214) |
| Other financial expenses | — | — | — | — | — | (178) |
| Net gains on derivative fair value | — | — | — | — | — | 1,791 |
| Net losses on foreign exchange | — | — | — | — | — | (7,014) |
Income before tax |
— | — | — | — | — | 18,994 |
| lncome tax | — | — | — | — | — | (3,606) |
Net income |
— | — | — | — | — | 15,388 |
EBITDA |
18,719 | 4,923 | 23,819 | 761 | (3,226) | 44,996 |
| EBITDA in % of net sales | 9,7% | 4,2% | 23,8% | 11,3% | ||
Assets and liabilities at Dec. 31, 2023 |
||||||
| Segment assets | 181,421 | 95,340 | 88,105 | — | 108,713 | 473,578 |
| Segment liabilities | (52,386) | (44,018) | (14,854) | — | (66,228) | (177,486) |
Net assets |
129,035 | 51,321 | 73,252 | — | 42,484 | 296,092 |
Other segment information |
||||||
| Additions to right-of-use asset | 4,044 | 1,010 | 164 | — | — | 5,217 |
| Additions to property, plant and equipment & intangible assets | 19,224 | 3,282 | 3,907 | — | — | 26,413 |
| Depreciation, amortization and impairment | 11,527 | 4,252 | 4,239 | — | — | 20,018 |
| Change in provisions | (443) | (894) | 172 | — | — | (1,165) |
| Other non-cash expense or (income) | (74) | 463 | (44) | 104 | 1,945 | 2,394 |
| Number of employees at year-end | 787 | 463 | 327 | — | — | 1,577 |
5-Jahresübersicht
In thousands of CHF |
2024 |
2023 |
2022 |
2021 |
2020 |
| Net sales | 445,362 | 397,453 | 586,395 | 513,721 | 395,816 |
| Operating income | 38,229 | 24,978 | 98,975 | 84,085 | 39,329 |
| In % of net sales | 8,6% | 6,3% | 16,9% | 16,4% | 9,9% |
| EBITDA | 60,380 | 44,996 | 118,913 | 102,749 | 58,616 |
| In % of net sales | 13,6% | 11,3% | 20,3% | 20,0% | 14,8% |
| Net income | 35,119 | 15,388 | 78,109 | 67,437 | 27,661 |
| In % of net sales | 7,9% | 3,9% | 13,3% | 13,1% | 7,0% |
| Free cash flow1 | 41,414 | (584) | 42,173 | 57,767 | 41,649 |
| In % of net sales | 9,3% | (0,1%) | 7,2% | 11,2% | 10,5% |
| Total assets | 531,169 | 473,578 | 556,801 | 482,341 | 429,271 |
| Shareholders' equity | 325,438 | 296,092 | 331,532 | 274,981 | 214,956 |
| In % of total assets | 61,3% | 62,5% | 59,5% | 57,0% | 50,1% |
| Number of employees (year-end) | |||||
| Switzerland | 690 | 586 | 647 | 565 | 474 |
| International | 1,120 | 991 | 1,116 | 1,006 | 929 |
| Total | 1,810 | 1,577 | 1,763 | 1,571 | 1,403 |
1 Net cash provided by operating activities and net cash (used in) investing activities, as per consolidated statement of cash flows.